parecoxib has been researched along with Fever in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kan, HP; Tan, JH; Zhang, GW; Zhou, L | 1 |
| Chen, JB; Chen, JC; Chen, MS; Qiu, HB; Wang, RJ; Xu, L; Zhang, YJ; Zhou, ZG | 1 |
| Blomqvist, A; Elander, L; Engström, L; Hamzic, N; Lönn, J; Nilsberth, C; Norell, M | 1 |
| Jain, NK; Kulkarni, SK; Padi, SS; Singh, S | 1 |
4 other study(ies) available for parecoxib and Fever
| Article | Year |
|---|---|
Parecoxib Improves the Outcomes of Acute Mild and Moderate Pancreatitis: A 3-Year Matched Cohort Study Based on a Prospective Database.
Topics: Acute Disease; Adult; Bacterial Infections; Cohort Studies; Cyclooxygenase 2 Inhibitors; Databases, Factual; Disease Progression; Female; Fever; Humans; Isoxazoles; Male; Middle Aged; Outcome Assessment, Health Care; Pancreatitis; Protective Agents; Severity of Illness Index | 2019 |
Parecoxib prevents complications in hepatocellular carcinoma patients receiving hepatic transarterial chemoembolization: a prospective score-matched cohort study.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cyclooxygenase 2 Inhibitors; Female; Fever; Humans; Isoxazoles; Length of Stay; Liver; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Pain Measurement; Pain, Postoperative; Palliative Care; Postoperative Nausea and Vomiting; Propensity Score; Prospective Studies | 2016 |
The role of interleukin-6 in lipopolysaccharide-induced fever by mechanisms independent of prostaglandin E2.
Topics: Animals; Body Temperature; Brain; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Fever; Genotype; Immunoassay; Immunohistochemistry; Interleukin-6; Isoxazoles; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mice, Knockout; Reverse Transcriptase Polymerase Chain Reaction; Tumor Necrosis Factor-alpha; Viscera | 2009 |
Pharmacological profile of parecoxib: a novel, potent injectable selective cyclooxygenase-2 inhibitor.
Topics: Acetic Acid; Animals; Carrageenan; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Edema; Endotoxins; Female; Fever; Formaldehyde; Hindlimb; Hyperalgesia; Injections, Intravenous; Isoenzymes; Isoxazoles; Ketorolac; Male; Mice; Pain; Pain Measurement; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Stomach | 2004 |